PONTE VEDRA, Fla., Dec. 11, 2025 -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current anticoagulation therapy, today announced the acquisition...
Eric Linsley will lead a discussion on "Partnering and Licensing in Neurotech" at the 2012 Neurotech Investing & Partnering Conference on May 21-22 in Boston.
News | 02. 21. 2012
Eric Linsley will lead a discussion on "Partnering and Licensing in Neurotech" at the 2012 Neurotech Investing & Partnering Conference on May 21-22 in Boston.
